Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vyne Therapeutics Inc.
Age
9–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Has facial acne vulgaris with:
* 20 to 50 inflammatory lesions (papules, pustules, and nodules);
* 25 to 100 noninflammatory lesions (open and closed comedones);
* no more than 2 nodules on the face; and
* IGA score of moderate (3) to severe (4)
Willing to use only the supplied non-medicated cleanser (Cetaphil Gentle Skin Cleanser) and to refrain from use of any other acne medication, medicated cleanser, excessive sun exposure, and tanning booths for the duration of the study
You may not be if
Acne conglobata, acne fulminans, secondary acne (chloracne, drug induced acne) or any dermatological condition of the face or facial hair (eg, beard, sideburns, mustache) that could interfere with the clinical evaluations
Sunburn on the face
Severe systemic disease, which might interfere with the conduct of the study or the interpretation of the results.
Abnormal baseline laboratory values that are considered clinically significant
Allergy to tetracycline-class antibiotics or to any ingredient in the study drug
Pseudomembranous colitis or antibiotic-associated colitis
Clareo Health | A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
